Aurinia Pharmaceuticals Inc. Income Taxes Paid
Aurinia Pharmaceuticals Inc. (AUPH) reported Income Taxes Paid of $496.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2024-02-15
- Aurinia Pharmaceuticals Inc. income taxes paid for fiscal 2023 was $496.00K, a 74.94% decline from fiscal 2022.
- Aurinia Pharmaceuticals Inc. income taxes paid for fiscal 2022 was $1.98M, a 670.04% increase from fiscal 2021.
- Aurinia Pharmaceuticals Inc. income taxes paid for fiscal 2021 was $257.00K, a 1.53% decline from fiscal 2020.
- Aurinia Pharmaceuticals Inc. income taxes paid for fiscal 2020 was $261.00K, a 342.37% increase from fiscal 2019.
| Period end | Income Taxes Paid 12 month |
|---|---|
| 2023-12-31 | $496.00K 10-K · filed 2024-02-15 |
| 2022-12-31 | $1.98M 10-K · filed 2024-02-15 |
| 2021-12-31 | $257.00K 10-K · filed 2024-02-15 |
| 2020-12-31 | $261.00K 10-K · filed 2023-02-28 |
| 2019-12-31 | $59.00K 10-K · filed 2022-02-28 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B |